[Congressional Record Volume 152, Number 66 (Wednesday, May 24, 2006)]
[House]
[Page H3223]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




  OMISSION FROM THE CONGRESSIONAL RECORD OF TUESDAY, MAY 23, 2006, AT 
                               PAGE H3077

  A portion of the following bill, H.R. 5384 was inadvertently omitted 
from the Record:
  After Sec. 748, insert:

       Sec. 749. (a) Section 1307(a)(6) of the Farm Security and 
     Rural Investment Act of 2002 (7 U.S.C. 7957(a)(6)) is 
     amended--
       (1) in the first sentence, by striking ``2006'' and 
     inserting ``2007''; and
       (2) in the second sentence, by striking ``2007'' and 
     inserting ``2008''.
       (b) The authority provided by section 1307(a)(6) of the 
     Farm Security and Rural Investment Act of 2002 (7 U.S.C. 
     7957(a)(6)), as amended by subsection (a), shall terminate 
     beginning with the 2008 crop of peanuts, and shall be 
     considered to have terminated notwithstanding section 257 of 
     the Balanced Budget and Emergency Deficit Control Act of 1985 
     (2 U.S.C. 907).

  After Sec. 750, insert:

       Sec. 751. The Secretary of Health and Human Services may 
     require the holder of an approved application for a drug 
     under section 505 of the Federal Food, Drug, and Cosmetic Act 
     to conduct one or more studies to confirm or refute an 
     empirical or theoretical hypothesis of a significant safety 
     issue with the drug (whether raised with respect to the 
     product directly or with respect to the class of the product) 
     that has been identified by the Secretary. If the holder 
     fails to comply with such a requirement (including a 
     requirement imposed before the date of the enactment of this 
     Act as a condition of the approval of an application under 
     such section), the Secretary may, after notice and an 
     opportunity for a hearing, consider the drug to be misbranded 
     under section 502 of the Federal Food, Drug, and Cosmetic 
     Act.

                          ____________________